Robin Howard W

President & CEO, DirectorNEKTAR THERAPEUTICS (NKTR) · full profile →Form 4 · filed Sep 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$431K
Net Open-Market Flow
-$431K
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 5, 2025Sell(S)3K$37.87$125K59K
Sep 5, 2025Sell(S)2K$38.82$86K57K
Sep 5, 2025Sell(S)1K$39.89$45K56K
Sep 4, 2025Sell(S)2K$32.37$62K66K
Sep 4, 2025Sell(S)1K$35.80$41K63K
Sep 4, 2025Sell(S)1K$33.54$50K64K
Sep 4, 2025Sell(S)613$34.40$21K64K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-113691) within minutes of acceptance. Every field above traces to the original document. Verify it directly: